Skip to Main Content

Sol-Gel Technologies Ltd. Ordinary Shares

SLGL Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
SLGL Income Statement
SLGL Balance Sheet
SLGL Cash Flow

Recent trades of SLGL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
SLGL Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
SLGL Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
SLGL Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by SLGL's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Method for preparing particles comprising metal oxide coating and particles with metal oxide coating Dec. 03, 2024
  • Patent Title: Stabilized microcapsules, method of their preparation and uses thereof Nov. 05, 2024
  • Patent Title: Core stabilized microcapsules, method of their preparation and uses thereof Aug. 27, 2024
  • Patent Title: Stabilized topical formulations containing core-shell microcapsules Aug. 06, 2024
  • Patent Title: Method for treatment of rosacea May. 21, 2024
  • Patent Title: Method for providing early onset of action in the treatment of rosacea Jan. 23, 2024
  • Patent Title: Pharmaceutical compositions comprising silica microspheres Jan. 09, 2024
  • Patent Title: Method for treatment of rosacea in patients aged 65 years and older Jan. 09, 2024
  • Patent Title: Treatment of skin disorders with compositions comprising an egfr inhibitor Apr. 25, 2023
  • Patent Title: Method for therapeutic treatment of rosacea Apr. 18, 2023
  • Patent Title: Method for treatment of rosacea Jan. 03, 2023
  • Patent Title: Method for long-term treatment of rosacea Aug. 30, 2022
  • Patent Title: Core stabilized microcapsules, method of their preparation and uses thereof Jul. 27, 2021
  • Patent Title: Process for the preparation of glycopyrrolate tosylate Mar. 23, 2021
  • Patent Title: Process for the preparation of glycopyrrolate tosylate Mar. 16, 2021
  • Patent Title: Method for providing early onset of action in the treatment of rosacea Mar. 16, 2021
  • Patent Title: Method for treatment of rosacea in patients aged 65 years and older Mar. 02, 2021
  • Patent Title: Pharmaceutical compositions comprising silica microspheres Sep. 22, 2020
  • Patent Title: Methods and compositions for the treatment of acne Jul. 07, 2020
  • Patent Title: Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof Jun. 23, 2020
  • Patent Title: Core stabilized microcapsules, method of their preparation and uses thereof May. 19, 2020
  • Patent Title: Formation of nanometric core-shell particles having a metal oxide shell Jan. 07, 2020
  • Patent Title: Core stabilized microcapsules, method of their preparation and uses thereof Dec. 24, 2019
  • Patent Title: Methods and compositions for the treatment of acne Sep. 24, 2019
  • Patent Title: Metal oxide coating of water insoluble ingredients Jan. 16, 2018
  • Patent Title: Compositions for the treatment of rosacea Jun. 27, 2017
  • Patent Title: Sustained release silica microcapsules Feb. 07, 2017
  • Patent Title: Compositions for topical application comprising a peroxide and retinoid Dec. 31, 2013
  • Patent Title: Composition exhibiting enhanced formulation stability and delivery of topical active ingredients May. 28, 2013
  • Patent Title: Agent-encapsulating micro-and nanoparticles, methods for preparation of same and products containing same Apr. 23, 2013
  • Patent Title: Microcapsules loaded with active ingredients and a method for their preparation Feb. 07, 2012
  • Patent Title: Composition exhibiting enhanced formulation stability and delivery of topical active ingredients Oct. 18, 2011
  • Patent Title: Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same Apr. 12, 2011
  • Patent Title: Composition exhibiting enhanced formulation stability and delivery of topical active ingredients Jul. 20, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of SLGL in WallStreetBets Daily Discussion

SLGL News

Recent insights relating to SLGL

CNBC Recommendations

Recent picks made for SLGL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SLGL

SLGL Top Shareholders
Shareholder
Shares Held
SLGL Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

SLGL Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view SLGL Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top